The latest prices for a box of different versions of Tobramycin Inhalation Solution (TOBI) announced

Introduction: The main active ingredient of Tobramycin Inhalation Solution (TOBI) is tobramycin. Tobramycin is a drug with strong antibacterial activity and has a good inhibitory effect on both Gram-negative bacteria and Gram-positive bacteria. Through inhalation administration, tobramycin can directly act on the respiratory mucosa and reduce the release of inflammatory mediators, thereby effectively alleviating the symptoms of patients with bronchiectasis.

The latest prices for a box of different versions of Tobramycin Inhalation Solution (TOBI) are announced

The version currently known is produced by Health$ Haibin Pharmaceutical Co., Ltd. Other versions of Tobramycin Inhalation Solution are not clear. Tobramycin inhalation solution may be sold in different packaging formats, such as single-dose vials, multi-dose bottles, etc., and therefore at different prices.

Tobramycin inhalation solution (TOBI) has been included in the medical insurance. The winning bid price of a box of 4 tubes (5ml:300mg) is 1014.4$, the winning price of a box of 28 tubes (5ml:300mg) is 7100.8$, and the winning price of a box of 1 tube (5ml:300mg) is 253.6$. Tobramycin solution for inhalation (TOBI) may be available in other strengths and at different prices.

May vary depending on region, supplier, medical insurance policy and other factors. If you need to obtain the latest price information, it is recommended to contact the drug supplier or a formal medical institution. At the same time, you can pay attention to the official announcements of drug manufacturers or contact their customer service to obtain more accurate price information.

Factors affecting the price of Tobramycin Inhalation Solution (TOBI)

1. R&D costs and patent rights: Tobramycin Inhalation Solution is China’s first antibiotic for inhalation. It is an improved new drug and has two invention patents. These patent rights and R&D investment account for an important proportion in drug pricing.

2. Production cost: including the cost of raw materials, production process, quality control and other links. Since tobramycin inhalation solution is a special pharmaceutical preparation, its production process may be more complex than that of ordinary drugs, thus affecting cost and price.

3. Market demand and supply: There are many patients with bronchiectasis in China, and large patient demand may affect the supply and price of drugs.

4. Medical insurance policy: Tobramycin inhalation solution has been included in the national medical insurance catalog. Changes in medical insurance policies, such as reimbursement ratios, drug classifications, etc., may affect the actual selling price of the drug.

5. Market competition: Currently, tobramycin inhalation solution is the first and only approved inhalation antibiotic in China, and its market exclusivity may affect its price. If similar products are launched in the future, market competition may affect prices.